Related Experiment Video

Updated: Oct 1, 2025

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.1K

Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment

Giorgia Foggetti1,2, Chuan Li3, Hongchen Cai4

  • 1Department of Internal Medicine (Medical Oncology), Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.

Molecular & Cellular Oncology
|March 7, 2022
PubMed

Insights

Researchers used in vivo models and CRISPR gene editing to understand how genetic changes impact EGFR-driven lung tumors. This work identified tumor suppressor pathways influencing tumor growth and response to targeted therapies.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Genetic alterations are key drivers of human tumors.
  • Understanding tumor suppressor pathways is crucial for cancer treatment.
  • Epidermal growth factor receptor (EGFR) mutations drive lung cancer and affect treatment response.

Purpose of the Study:

  • To investigate the role of tumor suppressor pathways in EGFR-driven lung tumor growth.
  • To determine how these pathways influence sensitivity to tyrosine kinase inhibitors.
  • To correlate findings with the human cancer mutational landscape and treatment outcomes.

Main Methods:

  • Utilized in vivo modeling to study tumor development.
  • Employed CRISPR/Cas9-mediated somatic genome editing for precise genetic manipulation.
  • Analyzed the impact of genetic alterations on tumor growth and drug sensitivity.

Main Results:

  • Identified specific tumor suppressor pathways affecting EGFR-driven lung tumor progression.
  • Demonstrated the influence of these pathways on sensitivity to tyrosine kinase inhibitors.
  • Findings reflect the broader mutational landscape and clinical outcomes in lung cancer patients.

Conclusions:

  • In vivo modeling and CRISPR editing are powerful tools for functional genomics in cancer research.
  • Tumor suppressor pathways play a significant role in modulating EGFR-driven lung tumorigenesis and therapy response.
  • This study provides insights into the genetic basis of lung cancer and potential therapeutic strategies.
Keywords:
EGFRLung cancermultiplexed in vivo genome editingtargeted therapytumor suppressor genes

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.9K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.3K

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K